| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9499bfaa0f7c82a0a4bc86f34406d477
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4754c9dee40486a7c206a85a4658270 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate |
2020-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_184625b32102b4e2f52273bc5a495a58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b806a98e25ccd8df972953a82a1ae3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcf9da0798a330b50dcd7e39f25cd31c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce78775aa53457fff035585de420240c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd6ed5ae02092ac25724d039676a6f0d |
| publicationDate |
2022-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3935192-A1 |
| titleOfInvention |
Methylation status of gasdermin e gene as cancer biomarker |
| abstract |
The present invention applies to the area of cancer diagnostics. In particular, the present invention is directed to a method for the ex vivo differential diagnosis between several cancer types in a subject based on the methylation status of the Gasdermin E ( GSDME ) gene. In a further aspect, the present invention relates to a method for the ex vivo differential diagnosis between several cancer types based on the methylation status of at least 2 CpG sites in the GSDME gene. |
| priorityDate |
2019-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |